Form 4 for MRK Merck & Co.
Accepted 2023-10-31 00:00:00 ET · period of report 2023-10-30 · accession 0001127602-23-026390 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-10-31 | 2023-10-30 | MRK | Oosthuizen Johannes Jacobus | Pres, U.S. Market | F - Tax | $102.82 | -451 | 20.3K | -2% | -$46.4K |
| D | 2023-10-31 | 2023-10-30 | MRK | Oosthuizen Johannes Jacobus | Pres, U.S. Market | M - OptEx | $102.82 | +915 | 20.7K | +5% | +$94.1K |
| D | 2023-10-31 | 2023-10-30 | MRK | Oosthuizen Johannes Jacobus | Pres, U.S. Market | M - OptEx | $0.00 | -915 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-30 | F | D | 451 | $102.82 | 20,271.66 | D | — | — | (F1) Holdings include shares acquired in dividend reinvestment transactions. |
| 2 | Common | Common Stock | 2023-10-30 | M | A | 915 | $102.82 | 20,722.66 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2023-10-30 | M | D | 915 | $0.00 | 0 | D | — · 2021-10-30 to 2023-10-30 | 915 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. (F3) These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 10/30/2021, 10/30/2022 and 10/30/2023. |